Australian Department of Industry, Tourism and Resources Report issue

Government Phase 1 Phase 4

Organization Overview

First Clinical Trial
2007
NCT00524927
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

methoxyflurane (penthrane) (1 trial)

sodium chloride (1 trial)

Drugs in Phase 1 Trials (1)

autologous ade1- latent membrane protein ctls (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lymphoma (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3